Rhythm Pharmaceuticals Inc (RYTM)
59.77
-0.30
(-0.50%)
USD |
NASDAQ |
Nov 14, 16:00
59.74
-0.03
(-0.05%)
After-Hours: 20:00
Rhythm Pharmaceuticals Free Cash Flow: -124.42M for Sept. 30, 2024
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| September 30, 2024 | -124.42M |
| June 30, 2024 | -163.06M |
| March 31, 2024 | -140.47M |
| December 31, 2023 | -136.20M |
| September 30, 2023 | -140.82M |
| June 30, 2023 | -164.05M |
| March 31, 2023 | -160.43M |
| December 31, 2022 | -177.71M |
| September 30, 2022 | -184.25M |
| June 30, 2022 | -177.43M |
| March 31, 2022 | -171.65M |
| December 31, 2021 | -151.44M |
| September 30, 2021 | -140.10M |
| June 30, 2021 | -127.00M |
| Date | Value |
|---|---|
| March 31, 2021 | -119.64M |
| December 31, 2020 | -122.19M |
| September 30, 2020 | -125.21M |
| June 30, 2020 | -131.91M |
| March 31, 2020 | -130.04M |
| December 31, 2019 | -126.14M |
| September 30, 2019 | -115.29M |
| June 30, 2019 | -98.69M |
| March 31, 2019 | -83.32M |
| December 31, 2018 | -62.78M |
| September 30, 2018 | -49.34M |
| June 30, 2018 | -40.58M |
| March 31, 2018 | -34.10M |
| December 31, 2017 | -29.46M |
Free Cash Flow Range, Past 5 Years
-184.25M
Minimum
Sep 2022
-119.64M
Maximum
Mar 2021
-145.71M
Average
-140.28M
Median
Free Cash Flow Benchmarks
| Eli Lilly and Co | -2.275B |
| TG Therapeutics Inc | -28.11M |
| Regeneron Pharmaceuticals Inc | 3.319B |
| Voyager Therapeutics Inc | -22.27M |
| Mirum Pharmaceuticals Inc | -39.22M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -25.22M |
| Cash from Investing (Quarterly) | -90.82M |
| Cash from Financing (Quarterly) | 2.492M |
| Free Cash Flow Per Share (Quarterly) | 0.2415 |
| Free Cash Flow to Equity (Quarterly) | 14.78M |
| Free Cash Flow to Firm (Quarterly) | 15.96M |
| Free Cash Flow Yield | -3.45% |